Leadership Overview
Torrent Pharma has 4 executives leading key functions including operations, financial strategy, quality assurance, and executive management.
Driven by a commitment to scientific excellence, Torrent Pharma advances global health through the development of high-quality, affordable medicines across diverse therapeutic areas while maintaining a robust international market presence.
Driven by a commitment to scientific excellence, Torrent Pharma advances global health through the development of high-quality, affordable medicines across diverse therapeutic areas while maintaining a robust international market presence.
Leadership Roles at Torrent Pharma
Sudhir Menon - Executive Director & Chief Financial Officer
Sudhir Menon, the Executive Director & Chief Financial Officer at Torrent Pharma, manages the fiscal health and long-term capital allocation strategies. Overseeing financial reporting and investor relations, the Executive Director & Chief Financial Officer ensures alignment with corporate growth targets. This leadership role involves evaluating investment opportunities in research and development to bolster the pipeline for central nervous system and diabetology treatments. By maintaining a disciplined balance sheet, Sudhir Menon directly impacts the financial stability required for international expansion. The Executive Director & Chief Financial Officer collaborates with the Board to execute strategic acquisitions and manage risk across diverse global markets. Through precise financial planning, Menon supports the infrastructure investments necessary for scientific innovation. This oversight of capital deployment ensures that the company remains a leader in the pharmaceutical sector. Ultimately, the Executive Director & Chief Financial Officer secures the resources needed to advance the mission of delivering high-quality medicines worldwide.
Hasmukh Patel - Chief Operating Officer
Hasmukh Patel, the Chief Operating Officer at Torrent Pharma, directs all internal manufacturing processes and supply chain logistics. Overseeing the production of cardiovascular and gastro-intestinal medications, the Chief Operating Officer ensures that advanced infrastructure meets global regulatory standards. This leadership role involves optimizing resource allocation across Indian facilities to maintain high-quality output. By streamlining complex manufacturing workflows, Hasmukh Patel directly impacts the company's ability to deliver affordable treatments to international markets. The Chief Operating Officer manages cross-functional teams to enhance operational efficiency and reduce production lead times. Through rigorous oversight of technical operations, Patel secures the scalability of the pharmaceutical portfolio. This focus on operational excellence supports the broader mission of providing accessible healthcare solutions. Ultimately, the Chief Operating Officer drives the internal growth necessary to sustain the competitive position of the organization within the global pharmaceutical landscape.
Vidyasagar Gotpagar - Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations )
Vidyasagar Gotpagar, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) at Torrent Pharma, architects the quality control frameworks for all contract manufacturing partnerships. Overseeing compliance across external production sites, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) ensures that every product meets stringent safety standards. This leadership role involves monitoring P2P processes to guarantee consistency in the delivery of vitamins, minerals, and cosmo-dermatology products. By auditing external manufacturing locations, Vidyasagar Gotpagar directly impacts the reliability of the supply chain. The Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) coordinates with marketing teams to align product quality with market expectations. Through rigorous oversight of quality protocols, Gotpagar mitigates operational risks and protects the reputation of the brand. This commitment to excellence ensures that patients receive safe, effective treatments. Ultimately, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) maintains the integrity of the global pharmaceutical portfolio.
Akash Vimal - Senior Executive Manager
Akash Vimal, the Senior Executive Manager at Torrent Pharma, coordinates cross-departmental initiatives to accelerate the development of pain management and anti-infective treatments. Overseeing project lifecycles, the Senior Executive Manager ensures that scientific research translates into market-ready solutions. This leadership role involves bridging the gap between laboratory innovation and commercial application to maximize therapeutic impact. By managing complex project timelines, Akash Vimal directly impacts the speed at which new medicines reach patients. The Senior Executive Manager facilitates communication between R&D teams and regional business units to ensure strategic alignment. Through the implementation of efficient project management methodologies, Vimal optimizes the use of the company's advanced scientific workforce. This focus on execution supports the broader goal of maintaining a leading position in the pharmaceutical industry. Ultimately, the Senior Executive Manager drives the organizational agility required to respond to evolving healthcare needs across diverse international markets.
Explore Leadership Teams in Manufacturing
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.
Company Leadership

AB
PAI Pharma is a privately held American pharmaceutical manufacturing company specializing in generic oral liquid medications, unit-dose pharmaceutical products, suspensions, syrups, injectable medicines, and patient-centric drug delivery solutions. Headquartered in Greenville, South Carolina, the organization operates as one of the leading manufacturers of liquid generic pharmaceuticals within the United States healthcare market. The company focuses heavily on producing high-quality oral liquid and unit-dose medications designed for hospitals, retail pharmacies, long-term care facilities, government healthcare systems, and institutional healthcare providers. The organization primarily generates revenue through the development, manufacturing, packaging, and distribution of prescription generic medicines and over-the-counter pharmaceutical products. Its product portfolio includes oral suspensions, oral solutions, elixirs, syrups, semi-solid medications, unit-dose pharmaceuticals, injectable medications, and specialty pharmaceutical formulations. PAI Pharma serves a wide customer base that includes retail pharmacy chains, independent pharmacies, acute care facilities, government agencies, institutional healthcare providers, and long-term care organizations throughout the United States.
Company Leadership KO
BR
ME
DC
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, commonly referred to as theranostics, which use molecularly targeted radiation to both image and treat cancer. Telix's pipeline is focused on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. Its lead commercial product, Illuccix, is an approved PSMA-PET/CT imaging agent for prostate cancer with regulatory clearance from the FDA, Australia's TGA, and Health Canada.
Company Leadership


CU
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
KW
FC